PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Scherm, M.G. ; Daniel, C.

miRNA-mediated immune regulation in islet autoimmunity and type 1 diabetes.

Front. Endocrin. 11:606322 (2020)
Postprint DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
The important role of microRNAs as major modulators of various physiological processes, including immune regulation and homeostasis, has been increasingly recognized. Consequently, aberrant miRNA expression contributes to the defective regulation of T cell development, differentiation, and function. This can result in immune activation and impaired tolerance mechanisms, which exert a cardinal function for the onset of islet autoimmunity and the progression to T1D. The specific impact of miRNAs for immune regulation and how miRNAs and their downstream targets are involved in the pathogenesis of islet autoimmunity and T1D has been investigated recently. These studies revealed that increased expression of individual miRNAs is involved in several layers of tolerance impairments, such as inefficient Treg induction and Treg instability. The targeted modulation of miRNAs using specific inhibitors, resulting in improved immune homeostasis, as well as improved methods for the targeting of miRNAs, suggest that miRNAs, especially in T cells, are a promising target for the reestablishment of immune tolerance.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
3.644
1.000
4
7
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Biomarker ; Immune Regulation ; Islet Autoimmunity ; Mirna ; Regulatory T Cell ; Type 1 Diabetes; Blood Mononuclear-cells; Helper T-cells; Foxp3 Expression; Decreased Expression; Mir-155 Contributes; Protein Expression; Cutting Edge; Target Genes; Microrna; Beta
Sprache englisch
Veröffentlichungsjahr 2020
HGF-Berichtsjahr 2020
ISSN (print) / ISBN 1664-2392
e-ISSN 1664-2392
Zeitschrift Frontiers in Endocrinology
Quellenangaben Band: 11, Heft: , Seiten: , Artikelnummer: 606322 Supplement: ,
Verlag Frontiers
Verlagsort Lausanne
Begutachtungsstatus Peer reviewed
Institut(e) Research Unit Type 1 Diabetes Immunology (TDI)
POF Topic(s) 30201 - Metabolic Health
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502191-001
Förderungen Excellence Program for Outstanding Female Scientists from the Helmholtz Association
Deutsche Forschungsgemeinschaft
German Center for Diabetes Research (DZD)
Research Group at Helmholtz Zentrum Munchen
DOI 10.3389/fendo.2020.606322
WOS ID WOS:000597399100001
Scopus ID 85097653686
PubMed ID 33329406
Erfassungsdatum 2021-01-12
[➜Korrektur melden]